ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathy
Article in Eye (May 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea
Article in BMC Health Services Research (December 2023)
Long-term longitudinal retinal changes after conventional and pattern scan laser panretinal photocoagulation in diabetic retinopathy
Article in Photodiagnosis and Photodynamic Therapy (October 2023)